How Medicare Part D affects your glaucoma patients: When lack of coverage is a concern, discussion between physician and patient is key.

The article discusses how the 2018 Medicare Part D formulary which excluded two new glaucoma drugs approved in late 2017 affect glaucoma patients. Topics covered include the need for doctors and patients need to explore options to lower the cost and discuss alternative treatments, ways to lower the price for patients who make the personal choice to buy medications and the importance to include clinical indicators and advantages and side effects of the new medications during patient discussion.